LYRA(Delisted)
Lyra Therapeutics·NASDAQ
--
--(--)
2.33 / 10
Underperform
Technical assessment scores 2.33/10, indicating poor structure. Recent candlestick patterns show long upper and lower shadows, both rated bearish with low scores (~2.2‑2.5). No bullish signals appear, suggesting downside risk.
Analysis Checks(0/2)
Long Upper Shadow
Score2.19/10
Win Rate37.93%
Hist. Signals87
Avg Return6.77%
Score2.19/10
Win Rate37.93%
Hist. Signals87
Avg Return6.77%
Long Lower Shadow
Score2.46/10
Win Rate39.73%
Hist. Signals73
Avg Return11.23%
Score2.46/10
Win Rate39.73%
Hist. Signals73
Avg Return11.23%
Long Upper Shadow
Score2.19/10
Win Rate37.93%
Hist. Signals87
Avg Return6.77%
Score2.19/10
Win Rate37.93%
Hist. Signals87
Avg Return6.77%
Long Lower Shadow
Score2.46/10
Win Rate39.73%
Hist. Signals73
Avg Return11.23%
Score2.46/10
Win Rate39.73%
Hist. Signals73
Avg Return11.23%
What is the current technical signals for LYRA?
- LYRA presents a Underperform setup with a Technical Score of 2.33/10. Key technical indicators highlight an RSI of 0.00 and a MACD of 0.00, with the trend anchored by the 50-Day SMA at 0.00.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
